Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Nov 18, 2022 10:00 AM - Nov 18, 2022 11:30 PM

(US Eastern Standard Time)

Harnessing the Power of Structured Content in Life Sciences: Practicalities, Challenges, and Opportunities in the Evolving Technology Landscape

Presenters

Katherine  Novak, MS

Katherine Novak, MS

Director, Epista Life Science, United States

Katherine Novak is a Director at Epista Life Sciences, specializing in regulatory affairs, clinical operations, and digital transformation. With experience across both industry and consulting, she helps life sciences organizations modernize business processes, implement technology solutions, and establish effective data governance strategies. Her expertise spans Regulatory Information Management (RIM), Clinical Trial Management Systems (CTMS), and electronic Trial Master Files (eTMF), with a focus on aligning technology, data, and operating models to support regulatory compliance and business objectives.

Nicholas  Rattenni, MS

Nicholas Rattenni, MS

Principle Consultant, Epista Inc., United States

Nicholas Rattenni is currently a Senior Advisory Consultant at NNIT within the US Life Sciences Advisory and Consulting team. Nick has worked in life sciences, focusing primarily on global regulatory initiatives and labeling including data standards and business development

Sarah  Powell, RAC

Sarah Powell, RAC

President, Powell Regulatory Services, United States

Sarah Powell is the President of Powell regulatory Services. Sarah has over 35 years of experience in pharmaceutical and related regulated industries. Sarah has worked as an independent consultant assisting clients with projects related to process improvements, standards development, and implementation of new technology. While in industry, Sarah performed roles within the Clinical, Quality, Regulatory Affairs and Regulatory Operations groups. Sarah has extensive experience with preparing regulatory submissions for biologic products for submission in the US and EU. She also has detailed knowledge on the requirements for the regulatory information systems.

Mitzi  Allred, PhD

Mitzi Allred, PhD

Director, Clinical Operations, Merck & Co., Inc., United States

Mitzi Allred, PhD, is Director of Clinical Operations at MSD with more than 20 years of experience in Regulatory Affairs, Clinical Operations, and digital transformation. At MSD, she advances protocol digitization, study design standardization, the one SOA framework and metadata-driven initiatives that enhance quality, efficiency, and traceability across clinical development. Mitzi is an active contributor to ICH and CDISC, collaborating with regulators, industry partners, and technology to advance digital clinical research. She serves on the ICH M11 Expert Working Group and participates in CDISC USDM Governance. Prior to joining the biopharmaceutical industry, she earned a PhD in Engineering and spent 15 years in aerospace.

John Henry April, MA

John Henry April, MA

Senior Director, Adaptive Content Strategy, Global Scientific Communications, Eli Lilly and Company, United States

Twenty-five years of drug development experience focused on medical writing. Highlights include developing content reuse and generative AI strategies for Lilly, retooling Lilly's medical writing staff to structure its content, leading a medical writing start-up in India, designing a Question Based Review (QBR) document development strategy, expanding medical writing's influence in clinical pharmacology, and playing key roles in developing integrated outsourcing strategies.

Todd  Georgieff, MBA, RPh

Todd Georgieff, MBA, RPh

Industry Lead for Pharma, RWS, Canada

Todd has been working in Drug Development for more than 30 years. He has extensive experience in clinical operations and also participated in and led many large-scale change and process improvement initiatives. Todd is currently Product Owner for implementation of a new Protocol authoring. Prior to his current role, he was Roche’s Program Lead for TransCelerate.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.